Effect of mindfulness based stress reduction in stage 0-III breast cancer survivors

2014 ◽  
Vol 19 (4) ◽  
pp. 219-220
Author(s):  
CED Lim ◽  
NCL Cheng ◽  
CA Lengacher
2010 ◽  
Vol 29 (2) ◽  
pp. 107-117 ◽  
Author(s):  
Cecile A. Lengacher ◽  
Versie Johnson-Mallard ◽  
Michelle Barta ◽  
Shirley Fitzgerald ◽  
Manolete S. Moscoso ◽  
...  

2017 ◽  
Vol 27 (2) ◽  
pp. 524-531 ◽  
Author(s):  
Cecile A. Lengacher ◽  
Richard R. Reich ◽  
Sophia Ramesar ◽  
Carissa B. Alinat ◽  
Manolete Moscoso ◽  
...  

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e24058-e24058
Author(s):  
Anne Hudson Blaes ◽  
Patricia Jewett ◽  
Prabhjot Nijjar ◽  
Susan Everson-Rose

e24058 Background: Breast cancer survivors on aromatase inhibitors (AIs) can develop endothelial dysfunction, a measure of increased CV risk. Stress modifying techniques such as MBSR may improve CV function and quality of life (QOL). We present data of a pilot study assessing the impact of MBSR on endothelial dysfunction and psychosocial outcomes. Methods: 31 women with locally advanced breast cancer and taking an AI were randomized 1:1 to 8 weekly MBSR classes or wait-list control. Subjects with tobacco use, known hypertension or hyperlipidemia were excluded. Participants completed surveys and vascular testing at baseline and 10 weeks. With the COVID-19 pandemic, MBSR classes were held on a virtual platform. Endothelial function was measured using the Endo-PAT2000 system; reductions in EndoPAT ratio (<1.6) are indicative of worsening endothelial function and increased CV risk. Questionnaires included the CDC’s 4-item Healthy Days Core Module (HRQOL), Patient Health Questionnaire (PHQ)-8 for depression, the Perceived Stress Scale, and the Generalized Anxiety Disorder Scale (GAD-7). Functional test markers were compared between groups using t-tests. Results: Baseline mean age was 59 years, body mass index was 28.4 kg/m2, mean systolic blood pressure was 128.1 mmHg and cholesterol was 226.9 mg/dL. These measures did not differ between groups. Baseline EndoPAT ratio (0.60) and follow up (0.52) were low in all participants. As statewide COVID-19 cases spiked, 3/31 participants did not return for a second assessment, and for another 5 participants, one EndoPAT ratio measurement was not interpretable. Both groups showed a decline in EndoPat ratio pre-to-post, but the decline among MBSR participants (all of whom completed the intervention) was five times less than that observed among controls [Table]. Groups did not differ on QOL or psychosocial outcomes. Conclusions: Breast cancer survivors on AIs have endothelial dysfunction, a measure of increased CV risk. Stress reduction techniques, using virtual platforms, are feasible and acceptable to this patient population, and may help improve endothelial function. Further research and longer follow up is warranted in understanding the long-term impact of these interventions on CV risk and psychosocial well-being. [Table: see text]


2010 ◽  
Vol 33 (8) ◽  
pp. 996-1016 ◽  
Author(s):  
Yaowarat Matchim ◽  
Jane M. Armer ◽  
Bob R. Stewart

The purpose of this study was to examine the effects of a MBSR program on physiological and psychological outcomes among early-stage breast cancer survivors. A quasi-experimental, pre-and posttest control group design was selected. The intervention group received the MBSR intervention. The control group received no MBSR intervention. ANOVA and ANCOVA were used to analyze data. The intervention group demonstrated statistically significant improvement in physiological and psychological outcomes including reduced blood pressure, heart rate, and respiratory rate and increased mindfulness state at the level of p = .05 to p = .001. The effects of MBSR on reducing stress in this sample were statistically significant on the physiological outcome (morning cortisol) at the measurement after the intervention completion, but this effect was not sustained at 1-month follow-up. MBSR showed a trend toward improving psychological outcomes by reducing mood disturbance in this sample.


2015 ◽  
Vol 17 (4) ◽  
pp. 393-404 ◽  
Author(s):  
Cecile A. Lengacher ◽  
Richard R. Reich ◽  
Kevin E. Kip ◽  
Carly L. Paterson ◽  
Hyun Y. Park ◽  
...  

Breast cancer (BC) survivors often report cognitive impairment, which may be influenced by single-nucleotide polymorphisms (SNPs). The purpose of this study was to test whether particular SNPs were associated with changes in cognitive function in BC survivors and whether these polymorphisms moderated cognitive improvement resulting from the Mindfulness-Based Stress Reduction for Breast Cancer (MBSR[BC]) program. BC survivors recruited from Moffitt Cancer Center and the University of South Florida’s Breast Health Program, who had completed adjuvant radiation and/or chemotherapy treatment, were randomized to either the 6-week MBSR(BC) program ( n = 37) or usual care (UC; n = 35) group. Measures of cognitive function and demographic and clinical history data were attained at baseline and at 6 and 12 weeks. A total of 10 SNPs from eight genes known to be related to cognitive function were analyzed using blood samples. Results showed that SNPs in four genes (ankyrin repeat and kinase domain containing 1 [ ANKK1], apolipoprotein E [ APOE], methylenetetrahydrofolate reductase [ MTHFR], and solute carrier family 6 member 4 [ SLC6A4]) were associated with cognitive impairment. Further, rs1800497 in ANKK1 was significantly associated with improvements in cognitive impairment in response to MBSR(BC). These results may help to identify individuals who would be better served by MBSR(BC) or other interventions.


Sign in / Sign up

Export Citation Format

Share Document